Condition: Hypogonadism, Male · Kidney Disease, Chronic · Sponsor: St. Louis University
This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).
This description comes directly from the study's public registry record.
Sandeep Dhindsa, MD · 314-977-9320 · sandeep.dhindsa@health.slu.edu
Jennifer Newman, RN · jennifer.newman@heath.slu.edu
Always discuss trial participation with your own doctor first.
| Saint Louis Univeristy | St Louis, Missouri, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05249634